Showing results (511-520 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|July 2, 2020
Iliac Bone Harvesting Techniques for Bone Reconstruction. Comparative Study Between Tricortical Bone Harvesting vs Trapdoor TechniqueJia-Fu Zhu, Wei-Xing Xu, Qiang Hu, et al.Therapeutics and Clinical Risk Management|July 7, 2012
Influence of treatment with alendronate on the speed of sound, an ultrasound parameter, of the calcaneus in postmenopausal Japanese women with osteoporosis: a clinical practice-based observational studyJun Iwamoto, Tetsuya Takada, Yoshihiro Sato, et al.Therapeutics and Clinical Risk Management|April 3, 2015
Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?Daisuke Asaoka, Akihito Nagahara, Yuji Shimada, et al.Therapeutics and Clinical Risk Management|March 14, 2015
Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a reviewJonathan Aguirre Valadez, Ignacio García Juárez, Rodolfo Rincón Pedrero, et al.Therapeutics and Clinical Risk Management|March 14, 2015
Risk of breast cancer recurrence in patients receiving manual lymphatic drainage: a hospital-based cohort studyPei-Chi Hsiao, Jung-Tai Liu, Chien-Liang Lin, et al.Therapeutics and Clinical Risk Management|May 23, 2014
Efficacy versus safety: the dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery diseaseGianmarco Iannopollo, Rita Camporotondo, Gaetano M De Ferrari, et al.Therapeutics and Clinical Risk Management|May 31, 2014
Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbiditiesKhaldoon M Alawneh, Basheer Y Khassawneh, Mahmoud H Ayesh, et al.Therapeutics and Clinical Risk Management|May 16, 2023
Management of Suspected Life-Threatening Perioperative Anaphylaxis and Risk Factors for Near-Fatal and Fatal Outcomes: A Retrospective Study in ChinaHuamei Cai, Xiaowen Liu, Dingyi Wang, et al.Therapeutics and Clinical Risk Management|January 28, 2015
Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertensionShusuke Yagi, Akira Takashima, Minoru Mitsugi, et al.Therapeutics and Clinical Risk Management|February 13, 2015
Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomesSanjay H Chotirmall, Mazen Al-Alawi, Thomas McEnery, et al.Pageof 256